Healthcare Industry
Filter News
Found 20,070 articles
-
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
4/23/2024
ImmunityBio, Inc., an immunotherapy company, announced that the U.S. Food and Drug Administration has approved ANKTIVA plus Bacillus Calmette-Guérin for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors.
-
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
4/23/2024
PharmAbcine, Inc. announced that the Company's U.S. subsidiary, Wincal Biopharm, Inc., will present preclinical findings on its innovative ocular drug delivery platform at the upcoming conference, Association for Research in Vision and Ophthalmology, the world's largest ophthalmology conference which will be held from May 5th to 9th, 2024 in Seattle, WA, United States.
-
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
4/22/2024
Profound Medical Corp. will announce its first quarter 2024 financial results after market close on Thursday, May 9, 2024.
-
Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results
4/22/2024
Nicox SA, an international ophthalmology company, provided the revenue and cash position for Nicox SA and its subsidiaries for the first quarter of 2024 and financial results for Nicox SA for the full year of 2023, as approved by the Board of Directors on April 19, 2024, and provided an update on key future milestones.
-
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
4/22/2024
OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its first quarter 2024 financial results on Monday, May 6, 2024, after the market closes.
-
Abeona Therapeutics Provides Regulatory Update on Pz-cel
4/22/2024
Abeona Therapeutics Inc. announced a regulatory update for prademagene zamikeracel.
-
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
4/22/2024
Johnson & Johnson will participate in the Bernstein’s 40th Annual Strategic Decisions Conference on Wednesday, May 29th, at the New York Hilton Midtown, New York, NY.
-
CIRCA SCIENTIFIC to Attend Heart Rhythm 2024
4/22/2024
CIRCA Scientific, Inc., a pioneer in the development of esophageal temperature monitoring, will be attending Heart Rhythm 2024 to showcase the company's latest technologies for Cardiac Electrophysiology.
-
Affinia Therapeutics to Present Data on Novel Cardiotropic and BBB-Penetrant AAV Capsids and Preclinical Efficacy and Safety in Genetic Cardiomyopathies and Sporadic ALS at the American Society of Gene & Cell Therapy 2024 Annual Meeting
4/22/2024
Affinia Therapeutics announced that new preclinical data on its novel AAV capsids for genetic cardiomyopathies and diseases of the central nervous system such as amyotrophic lateral sclerosis, as well as the Company's high-yield manufacturing process, will be presented in several oral and poster sessions at the American Society of Gene and Cell Therapy 2024 Annual Meeting, being held May 7-11, 2024 in Baltimore, MD and virtually.
-
Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results
4/22/2024
ImmunoPrecise Antibodies Ltd. has recently announced an expansion of its already successful LENSai TM Platform.
-
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
4/22/2024
Voyager Therapeutics, Inc. announced that it will present a broad set of data related to its TRACER™ capsid discovery platform and TRACER-driven gene therapy programs across 12 oral and poster presentations at the upcoming American Society of Gene & Cell Therapy’s 27th annual meeting taking place in Baltimore, May 7-11.
-
IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
4/22/2024
IDEAYA Biosciences, Inc. announced selection of a move-forward Phase 2 expansion dose for IDE397 monotherapy in MTAP-deletion squamous non-small cell lung cancer, based on adverse event profile and preliminary clinical efficacy observed, including multiple partial responses by RECIST 1.1.
-
Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide
4/22/2024
ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell solutions for use in research, drug development and clinical oncology, is pleased to announce that the European Patent Office has granted a European Patent for its innovative CellKeep™ slide.
-
Ahead of launching its Humira biosimilar Simlandi, Alvotech and Teva on Friday announced they have signed a long-term agreement with an undisclosed strategic partner to help boost patient access to the drug.
-
Grifols 2023 Annual Report on Form 20-F filed with the SEC
4/19/2024
Grifols, S.A., a global healthcare company and leading manufacturer of plasma-derived medicines, announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission.
-
Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award
4/19/2024
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in the National Academy of Sciences building in Washington D.C.
-
Stacey Lasser of Mednet to Present at the 2nd Annual Clinical Outsourcing Group New England Conference in Boston
4/19/2024
Mednet, a healthcare technology company, today announced Senior Project Manager Stacey Lasser will present at the 2nd Annual Clinical Outsourcing Group (COG) New England conference in Boston, Massachusetts from April 23 – 24, 2024.
-
Nearly all doses of Eli Lilly’s highly popular weight-loss drug Zepbound and type 2 diabetes medication Mounjaro will have limited availability through the second quarter of 2024, according to the regulator.
-
GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging
4/18/2024
GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence, advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health.
-
Intuitive Announces First Quarter Earnings 2024
4/18/2024
Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced financial results for the quarter ended March 31, 2024.